News, talk and articles
The latest news from PTC
-
Debunking Myths About PKU
In honor of International PKU Awareness Day, June 28, members of the community helped us to debunk common myths about PKU. Watch the video below to hear from PKU advocates, healthcare professionals, a person living with PKU and a caregiver as they share the facts: International PKU Awareness Day is a global day hosted by… -
PTC International Ireland: A Decade of Serving Patients Around the World
Since 2014, the PTC office in Ireland has been the company’s international headquarters and a regional hub. With nine departments and more than 50 employees*, the cross-functional teams facilitate supply of PTC’s medicines across 50+ geographies, manage global quality operations and global pharmacovigilance activities as well as commercial sales and finances for Europe, Middle East… -
PTC Celebrates 10 Years of Impact in Europe
It has been 10 years since PTC entered the European market with a mission to improve the lives of people living with rare diseases. In the past decade, we have pioneered transformative progress and created possibilities for the rare disease community across Europe. PTC was founded with the mission to leverage its novel drug discovery… -
Navigating Clinical Trials
Clinical trials provide the medical community with valuable research and data that helps to facilitate the development of new and potentially life-saving therapies. By participating in a clinical trial, you are taking an active role in the development and approval of new medicines and treatments. There is a lot to learn about clinical trials –… -
What You Need to Know About Ferroptosis & Friedreich Ataxia (FA)
An Informative Q&A with Jonathan Cherry, Global Project Leader Our research efforts at PTC are focused on two scientific platforms – splicing and ferroptosis and inflammation – where PTC has unique expertise to discover and advance innovative therapies to the clinic. We recently sat down with Jonathan Cherry, Global Project Leader, to learn more about… -
Highlighting Voices of the HD Community
In honor of Huntington’s disease (HD) Awareness Month, we are highlighting inspiring and impactful voices from the HD community. Watch the video below to learn more about this rare, hereditary, genetic disorder of the central nervous system, and hear from the global community about their hope for the future of HD. -
PTC Wins Gallup’s 2024 Don Clifton Strengths-Based Culture Award
We are excited to announce that PTC has been named a winner of the 2024 Don Clifton Strengths-Based Culture Award from Gallup. This is the third time PTC has won this award that recognizes organizations with strong workplace cultures that get the best out of their employees by developing their strengths and placing them at… -
Making an Environmental Impact at PTC
At PTC, we strive to be good citizens of the world and make change for a better planet, because as a science-based company, we understand the impact people have on the environment. We pride ourselves not only on our innovative work but on our commitment to sustainability and social responsibility. To bring this mission to… -
What You Need to Know About Ferroptosis
Our research efforts at PTC are focused on two scientific platforms – splicing and ferroptosis and inflammation – where PTC has unique expertise to discover and advance innovative therapies to the clinic. We recently sat down with Jeff Trimmer, Senior VP, Research Site Head, to learn more about ferroptosis, how it relates to inflammation and… -
Honoring International Women’s Day Through Inclusion and Pride
When asked why it’s important to recognize Women’s History Month (WHM) in March, women leaders at PTC agree: WHM is a significant moment in time to honor the achievements and impact of women across history. “Women’s History Month demonstrates the vast contributions women have made across all areas – politics, music, fine arts, drama, literature,…